Clinical Trial Update: S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial (S9924 R115777) evaluating tipifarnib in locally advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Zarnestra (tipifarnib) (tipifarnib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED